Lung Cancer With EGFR Exon 19 and L858R Mutations: The Optimal Front Line Therapy
Jonathan Riess, MD, MS
Applying New Endocrine and Targeted Agents to the Treatment of Hormone Receptor Positive, HER2 Negative Breast Cancer
Mariana Chavez-McGregor, MD, MSc, FASCO
Artificial Intelligence and Modern Medical Practice: Do’s and Don’ts
Eduardo Smith Singares, MD, FACS, FCCM
Lifestyle Modifications in Reducing Risk of Recurrence
Adrienne M. Vazquez Guerra, MSN, ACNP-BC, AOCN®
Cervical and Uterine Cancer: Novel Advances in Personalized Medicine in 2024
Kathleen N. Moore, MD, MS
